Conjugate and Compostion for Treating Cancer

The novel aspect of this patented technology lies in the specific combination of a functionalised nanocarrier ( A single-walled carbon nanotube with polyethylene glycol), targeting moiety (folic acid), and unique plant extract compounds (which and known for their medicinal properties and potential anti-cancer effects), which together offer a targeted and potentially less harmful alternative to traditional chemotherapy. The specific method of conjugation and the use of selected plant extracts for their anti-cancer properties represent significant innovations in the field of cancer treatment.

By introducing a novel conjugate that leverages targeted delivery, natural plant extracts, and advanced nanotechnology, this technology offers a promising alternative to traditional chemotherapy. This approach not only aims to improve the effectiveness of cancer treatment but also seeks to minimise side effects, overcome drug resistance, and reduce toxicity, ultimately enhancing patient outcomes and quality of life.